                                                                                                                                                                  I




                                                                   113TH CONGRESS
                                                                      1ST SESSION                             H. R. 80
                                                                      To provide for research and education with respect to triple-negative breast
                                                                                            cancer, and for other purposes.




                                                                                 IN THE HOUSE OF REPRESENTATIVES
                                                                                                         JANUARY 3, 2013
                                                                       Ms. JACKSON           LEE introduced the following bill; which was referred to the
                                                                                                Committee on Energy and Commerce




                                                                                                             A BILL
                                                                     To provide for research and education with respect to triple-
                                                                           negative breast cancer, and for other purposes.
                                                                     1               Be it enacted by the Senate and House of Representa-
                                                                     2 tives of the United States of America in Congress assembled,
                                                                     3     SECTION 1. SHORT TITLE.
                                                                     4               This Act may be cited as the ‘‘Triple-Negative Breast
                                                                     5 Cancer Research and Education Act of 2013’’.
                                                                     6     SEC. 2. FINDINGS.
                                                                     7               Congress finds as follows:
                                                                     8                        (1) Breast cancer accounts for 1 in 4 cancer di-
rfrederick on DSK6VPTVN1PROD with                                    9               agnoses among women in this country.
                                                                                                                              2
                                                                     1                        (2) The survival rate for breast cancer has in-
                                                                     2               creased to 90 percent for White women and 78 per-
                                                                     3               cent for African-American women.
                                                                     4                        (3) African-American women are more likely to
                                                                     5               be diagnosed with larger tumors and more advanced
                                                                     6               stages of breast cancer despite a lower incidence
                                                                     7               rate.
                                                                     8                        (4) Early detection for breast cancer increases
                                                                     9               survival rates for breast cancer, as evidenced by a 5-
                                                                   10                year relative survival rate of 98 percent for breast
                                                                   11                cancers that are discovered before the cancer
                                                                   12                spreads beyond the breast, compared to 23 percent
                                                                   13                for stage IV breast cancers.
                                                                   14                         (5) Triple-negative breast cancer is a term used
                                                                   15                to describe breast cancers whose cells do not have
                                                                   16                estrogen receptors and progesterone receptors, and
                                                                   17                do not have an excess of the HER2 protein on their
                                                                   18                sources.
                                                                   19                         (6) It is estimated that between 10 and 20 per-
                                                                   20                cent of female breast cancer patients are diagnosed
                                                                   21                with triple-negative breast cancer, and studies indi-
                                                                   22                cate the prevalence of triple-negative breast cancer is
rfrederick on DSK6VPTVN1PROD with                                  23                much higher.
                                                                                •HR 80 IH

                                                                                                                              3
                                                                     1                        (7) Triple-negative breast cancer most com-
                                                                     2               monly affects African-American women, followed by
                                                                     3               Hispanic women.
                                                                     4                        (8) Triple-negative breast cancer is a very ag-
                                                                     5               gressive form of cancer which affects women under
                                                                     6               the age of 50 across all racial and socioeconomic
                                                                     7               backgrounds.
                                                                     8                        (9) African-American women are 3 times more
                                                                     9               likely to develop triple-negative breast cancer than
                                                                   10                White women.
                                                                   11                         (10) Triple-negative breast cancer tends to
                                                                   12                grow and spread more quickly than most other types
                                                                   13                of breast cancer.
                                                                   14                         (11) Like other forms of breast cancer, triple-
                                                                   15                negative breast cancer is treated with surgery, radi-
                                                                   16                ation therapy, or chemotherapy.
                                                                   17                         (12) Early-stage detection of triple-negative
                                                                   18                breast cancer is the key to survival because the
                                                                   19                tumor cells lack certain receptors, and neither hor-
                                                                   20                mone therapy nor drugs that target these receptors
                                                                   21                are effective against these cancers; therefore, early
                                                                   22                detection and education is vital.
                                                                   23                         (13) Current research and available data do not
rfrederick on DSK6VPTVN1PROD with                                  24                provide adequate information on—
                                                                                •HR 80 IH

                                                                                                                              4
                                                                     1                                 (A) the rates of prevalence and incidence
                                                                     2                        of triple-negative breast cancer in African-
                                                                     3                        American, Hispanic, and other minority women;
                                                                     4                                 (B) he costs associated with treating tri-
                                                                     5                        ple-negative breast cancer; and
                                                                     6                                 (C) the methods by which triple-negative
                                                                     7                        breast cancer may be prevented or cured in
                                                                     8                        these women.
                                                                     9     SEC. 3. RESEARCH WITH RESPECT TO TRIPLE-NEGATIVE
                                                                   10                              BREAST CANCER.
                                                                   11                (a) RESEARCH.—The Director of the National Insti-
                                                                   12 tutes of Health (in this section referred to as the ‘‘Direc-
                                                                   13 tor of NIH’’) shall expand, intensify, and coordinate pro-
                                                                   14 grams for the conduct and support of research with re-
                                                                   15 spect to triple-negative breast cancer.
                                                                   16                (b) ADMINISTRATION.—The Director of NIH shall
                                                                   17 carry out this section through the appropriate institutes,
                                                                   18 offices, and centers of the National Institutes of Health,
                                                                   19 including the Eunice Kennedy Shriver National Institute
                                                                   20 of Child Health and Human Development, the National
                                                                   21 Institute of Environmental Health Sciences, the Office of
                                                                   22 Research on Women’s Health, and the National Institute
                                                                   23 on Minority Health and Health Disparities.
rfrederick on DSK6VPTVN1PROD with                                  24                (c) COORDINATION                   OF        ACTIVITIES.—The Director of
                                                                   25 the Office of Research on Women’s Health shall coordi-


                                                                                •HR 80 IH

                                                                                                                              5
                                                                     1 nate activities under this section among the institutes, of-
                                                                     2 fices, and centers of the National Institutes of Health.
                                                                     3               (d) AUTHORIZATION                        OF   APPROPRIATIONS.—For the
                                                                     4 purpose of carrying out this section, there are authorized
                                                                     5 to be appropriated $500,000 for each of the fiscal years
                                                                     6 2014 through 2016.
                                                                     7     SEC. 4. EDUCATION AND DISSEMINATION OF INFORMATION
                                                                     8                             WITH            RESPECT                 TO         TRIPLE-NEGATIVE
                                                                     9                             BREAST CANCER.

                                                                   10                (a) TRIPLE-NEGATIVE BREAST CANCER PUBLIC
                                                                   11 EDUCATION PROGRAM.—The Secretary of Health and
                                                                   12 Human Services, acting through the Director of the Cen-
                                                                   13 ters for Disease Control and Prevention, shall develop and
                                                                   14 disseminate to the public information regarding triple-neg-
                                                                   15 ative breast cancer, including information on—
                                                                   16                         (1) the incidence and prevalence of triple-nega-
                                                                   17                tive breast cancer among women;
                                                                   18                         (2) the elevated risk for minority women to de-
                                                                   19                velop triple-negative breast cancer; and
                                                                   20                         (3) the availability, as medically appropriate, of
                                                                   21                a range of treatment options for symptomatic triple-
                                                                   22                negative breast cancer.
                                                                   23                (b) DISSEMINATION                        OF     INFORMATION.—The Sec-
rfrederick on DSK6VPTVN1PROD with                                  24 retary may disseminate information under subsection (a)
                                                                   25 directly or through arrangements with nonprofit organiza-


                                                                                •HR 80 IH

                                                                                                                              6
                                                                     1 tions, consumer groups, institutions of higher education,
                                                                     2 Federal, State, or local agencies, or the media.
                                                                     3               (c) AUTHORIZATION                        OF   APPROPRIATIONS.—For the
                                                                     4 purpose of carrying out this section, there are authorized
                                                                     5 to be appropriated such sums as may be necessary for
                                                                     6 each of the fiscal years 2014 through 2016.
                                                                     7     SEC. 5. INFORMATION TO HEALTH CARE PROVIDERS WITH
                                                                     8                             RESPECT TO TRIPLE-NEGATIVE BREAST CAN-
                                                                     9                             CER.

                                                                   10                (a) DISSEMINATION                        OF     INFORMATION.—The Sec-
                                                                   11 retary of Health and Human Services, acting through the
                                                                   12 Administrator of the Health Resources and Services Ad-
                                                                   13 ministration, shall develop and disseminate to health care
                                                                   14 providers information on triple-negative breast cancer for
                                                                   15 the purpose of ensuring that health care providers remain
                                                                   16 informed about current information on triple-negative
                                                                   17 breast cancer. Such information shall include the elevated
                                                                   18 risk for minority women to develop triple-negative breast
                                                                   19 cancer and the range of available options for the treatment
                                                                   20 of symptomatic triple-negative breast cancer.
                                                                   21                (b) AUTHORIZATION                        OF   APPROPRIATIONS.—For the
                                                                   22 purpose of carrying out this section, there are authorized
                                                                   23 to be appropriated such sums as may be necessary for
rfrederick on DSK6VPTVN1PROD with                                  24 each of the fiscal years 2014 through 2018.
                                                                                •HR 80 IH

                                                                     1     SEC. 6. DEFINITION.                                7
                                                                     2               In this Act, the term ‘‘minority women’’ means
                                                                     3 women who are members of a racial and ethnic minority
                                                                     4 group, as defined in section 1707(g) of the Public Health
                                                                     5 Service Act (42 U.S.C. 300u–6(g)).
                                                                                                                              Æ
rfrederick on DSK6VPTVN1PROD with




                                                                                •HR 80 IH

